Calliditas Therapeutics AB (publ) (CALT)
NASDAQ: CALT · IEX Real-Time Price · USD
22.19
+0.29 (1.32%)
At close: May 17, 2024, 11:17 AM
21.26
-0.93 (-4.19%)
After-hours: May 17, 2024, 4:06 PM EDT
CALT Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for CALT stock have an average target of 39.33, with a low estimate of 18 and a high estimate of 50. The average target predicts an increase of 77.24% from the current stock price of 22.19.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 22, 2024.
Analyst Ratings
The average analyst rating for CALT stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +125.33% | Feb 22, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +125.33% | Nov 27, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +125.33% | Oct 16, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +125.33% | Aug 21, 2023 |
Guggenheim | Guggenheim | Hold Maintains $21 → $18 | Hold | Maintains | $21 → $18 | -18.88% | Aug 18, 2023 |
Financial Forecast
Revenue This Year
2.00B
from 1.21B
Increased by 65.63%
Revenue Next Year
3.44B
from 2.00B
Increased by 72.09%
EPS This Year
4.03
from -17.38
EPS Next Year
19.75
from 4.03
Increased by 389.63%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 2.5B | 4.6B | 6.9B | 10.2B | 13.0B |
Avg | 2.0B | 3.4B | 4.8B | 7.0B | 7.7B |
Low | 1.8B | 2.4B | 2.9B | 3.8B | 3.9B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 107.6% | 128.6% | 99.4% | 110.7% | 85.3% |
Avg | 65.6% | 72.1% | 40.3% | 45.8% | 9.7% |
Low | 47.2% | 18.4% | -15.6% | -21.4% | -44.4% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 7.35 | 33.60 | 66.15 | 111.91 | 153.15 |
Avg | 4.03 | 19.75 | 34.60 | 109.78 | 150.23 |
Low | -0.80 | 9.15 | 16.51 | 104.45 | 142.94 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | 732.9% | 234.9% | 223.4% | 39.5% |
Avg | - | 389.6% | 75.2% | 217.2% | 36.9% |
Low | - | 126.9% | -16.4% | 201.8% | 30.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.